RECQL5 and Leigh syndrome: In contrast, the variants in the main candidate susceptibility gene in non-LS patients, RECQL5, were not high-confidence LoF variant and the genes was not affected in any of the 6 tumors from 4 variant carriers or any of the 22 tumors from all non-LS patients.